Maria Dalla Pozza

Maria Dalla Pozza

Auto-generated profile, based on publicly available information

Maria Dalla Pozza

Institut Pasteur, Université Paris Cité, CNRS UMR 3523, Unit of Bioorganic Chemistry of Nucleic Acids, 28 rue du Docteur Roux, 75724 Paris Cedex 15, France

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 August 2022 in Chemical Science
Verified
Journal Article
Open access
PDF file
MPMaria Dalla Pozza
Maria Dalla Pozza
AAAhmad Abdullrahman
Ahmad Abdullrahman
CCChristine Cardin
Christine Cardin
Gilles GasserGilles Gasser
Gilles Gasser
JHJames P Hall
James P Hall
DNA is a strikingly flexible molecule and can form a variety of secondary structures, including the triple helix, which is the subject of this review. The DNA triplex may be formed naturally, during homologous recombination, or can be formed by the introduction of a synthetic triplex forming oligonucleotide (TFO) to a DNA duplex. As the TFO will bind to the duplex with sequence specificity, there is significant interest in developing TFOs with potential therapeutic applications, including using TFOs as a delivery mechanism for compounds able to modify or damage DNA. However, to combine triplexes with functionalised compounds, a full understanding of triplex structure and chemical modification strategies, which may increase triplex stability or in vivo degradation, is essential – these areas will be discussed in this review. Ruthenium polypyridyl complexes, which are able to photooxidise DNA and act as luminescent DNA probes, may serve as a suitable photophysical payload for a TFO system and the developments in this area in the context of DNA triplexes will also be reviewed.

4 April 2023 in Dalton Transactions
Verified
Journal Article
Closed access
PDF file
SBSara Benetti
Sara Benetti
MPMaria Dalla Pozza
Maria Dalla Pozza
LBLorenzo Biancalana
Lorenzo Biancalana
SZStefano Zacchini
Stefano Zacchini
Gilles GasserGilles Gasser
Gilles Gasser
Fabio MarchettiFabio Marchetti
Fabio Marchetti
Novel diiron vinyliminium complexes, [Fe2Cp2(CO)(μ-CO){μ-η1:η3-C(R3)CHCNMe(R2)}]CF3SO3 (2a–f; R2 = 4-C6H4OMe, Cy or Me; R3 = Cy, CH2Cy or 4-C6H4OMe; Cy = cyclohexyl, Cp = η5-C5H5), were synthesized by alkyne insertion reaction from the corresponding diiron aminocarbyne precursors, and isolated in 53–98% yields. The reactions of selected vinyliminium complexes with N2CHCO2Et and MeONa, followed by N-methylation, afforded the new hydrazone-vinyliminium [Fe2Cp2(CO)(μ-CO){μ-η1:η3-C(R3)C(NMeNCHCO2Et)CN(R1)(R2)}]X (4a–c; R1 = Me or CH2Ph; R2 = Cy, CH2Ph or Me; R3 = 4-C6H4OMe or Ph; X = NO3 or CF3SO3), in 53–67% yields. Compounds 2a–f and 4a–c were fully characterized by IR and multinuclear NMR spectroscopy, and the structures of 2a–c were ascertained by single crystal X-ray diffraction. Moreover, D2O solubility, Log Pow coefficients and the fraction of each complex preserved in aqueous media after 72 hours at 37 °C were determined by 1H NMR and UV-Vis methods. The antiproliferative activity of 2a–f and 4a–c was measured on the mouse colon CT26 and human glioblastoma U87 cancer cell lines, and on the retinal pigment epithelial RPE-1 non-cancerous cell line. Complexes 2a,d,e, which all bear R3 = Cy, stand out for their performance and their selectivity towards cancer cells. To give insight into the mechanism of action, the effect of 2a, 2d, 2e, 2f, 4b and 4c on the mitochondrial respiration was evaluated in CT26 cells (Seahorse Mito stress test), revealing a correlation between the effectiveness of the complexes and their influence on the mitochondrial metabolism.

11 March 2025 in Dalton Transactions
Verified
Journal Article
Open access
TSThomas Scattolin
Thomas Scattolin
ECEnrico Cavarzerani
Enrico Cavarzerani
DADario Alessi
Dario Alessi
MMMatteo Mauceri
Matteo Mauceri
EBEleonora Botter
Eleonora Botter
FRFlavio Rizzolio
Flavio Rizzolio
High-Grade Serous Ovarian Cancer (HGSOC) is the most common and lethal subtype of ovarian cancer, known for its high aggressiveness and extensive genomic alterations.

21 July 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
EVEloi Vincent
Eloi Vincent
VMVictoria Maola
Victoria Maola
CLClément Lopez
Clément Lopez
MBMarc Borie-Guichot
Marc Borie-Guichot
MPMaria Dalla Pozza
Maria Dalla Pozza
MDMarc Delarue
Marc Delarue
Chemical modifications expand the functional repertoire of nucleic acids, but the extent to which complex glycans can be integrated into genetic polymers remains largely unexplored. Glycosylated nucleic acids, including glycoRNAs and bacteriophage genomes, are emerging as key mediators of host-pathogen interactions, yet their synthetic accessibility is severely limited by the inability of polymerases to process substrates bearing simultaneous base and backbone modifications. Here we report the directed evolution of a family B DNA polymerase that enables the synthesis of glycosylated xeno-nucleic acids (XNAs). Using fluorescence-activated droplet sorting, we identified an engineered polymerase, termed G2, that efficiently incorporates nucleotides bearing mono- to trisaccharide base-appendages together with C2’ substitutions, yielding XNAs containing up to 30% glycosylated bases. Deep sequencing of >93,000 chimeras reveals that this activity arises from epistatic networks concentrated within catalytic domains. These results establish a route to glycan-encoded nucleic acids and advance polymerase engineering for chemically expanded therapeutics.